An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

NCT00597116 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment stopped according to early stopping rule (by protocol)

Conditions

Mesothelioma

Interventions

DRUG: Vinorelbine
DRUG: Vandetanib

Sponsor

Genzyme, a Sanofi Company